摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1a,2,3,7b-Tetrahydro-α-[(2-nitro-1H-imidazol1-yl)methyl]-1H-naphth[1,2-b]azirine-1-ethanol | 120277-98-7

中文名称
——
中文别名
——
英文名称
1a,2,3,7b-Tetrahydro-α-[(2-nitro-1H-imidazol1-yl)methyl]-1H-naphth[1,2-b]azirine-1-ethanol
英文别名
1-(1a,2,3,7b-Tetrahydronaphtho[1,2-b]azirin-1-yl)-3-(2-nitroimidazol-1-yl)propan-2-ol
1a,2,3,7b-Tetrahydro-α-[(2-nitro-1H-imidazol1-yl)methyl]-1H-naphth[1,2-b]azirine-1-ethanol化学式
CAS
120277-98-7
化学式
C16H18N4O3
mdl
——
分子量
314.344
InChiKey
OIIUJWNOPYVMGL-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.3
  • 重原子数:
    23
  • 可旋转键数:
    4
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.44
  • 拓扑面积:
    86.9
  • 氢给体数:
    1
  • 氢受体数:
    5

反应信息

  • 作为产物:
    描述:
    1a,2,3,7b-四氢-1H-萘并[1,2-b]氮丙啶1-(2,3-环氧丙基)-2-硝基咪唑甲醇 为溶剂, 反应 3.0h, 以30%的产率得到1a,2,3,7b-Tetrahydro-α-[(2-nitro-1H-imidazol1-yl)methyl]-1H-naphth[1,2-b]azirine-1-ethanol
    参考文献:
    名称:
    A new class of analog of the bifunctional radiosensitizer .alpha.-(1-aziridinylmethyl)-2-nitro-1H-imidazole-1-ethanol (RSU 1069): the cycloalkylaziridines
    摘要:
    A series of compounds related to alpha-(1-aziridinylmethyl)-2-nitro-1H-imidazole-1-ethanol (RSU 1069, 1) were synthesized and evaluated as selective hypoxic cell cytotoxic agents and as radiosensitizers. The aziridine moiety was replaced with a number of other potential alkylating groups including cycloalkylaziridines and azetidines. The data indicated that modification of the aziridine of 1 resulted in a substantial decrease in the ability of the compounds to selectively kill hypoxic cells. However, these modifications did not affect the compounds' in vitro radiosensitizing activity since many of the derivatives were as potent as 1. All of the compounds that were evaluated in vivo were less toxic than 1, and several members of this series had significant activity. The best compound was trans-alpha-[[(4-bromotetrahydro-2H-pyran-3-yl)amino]methyl]-2-nitro-1H-imidazole-1-ethanol (18), which, due to its activity and log P value, is a candidate for additional in vivo studies.
    DOI:
    10.1021/jm00112a026
点击查看最新优质反应信息

文献信息

  • 2-nitroimidazole derivatives useful as radiosensitizers for hypoxic tumor cells
    申请人:WARNER-LAMBERT COMPANY
    公开号:EP0302416A1
    公开(公告)日:1989-02-08
    α-[(2-nitro-1H-imidazol-1-yl)methyl]-(A) azaridinylethanol derivatives of formula I and the corresponding aziridine-ring opened analogs are useful as radiation sensitizers for X-irradiation therapy of tumors.
    式 I 的α-[(2-硝基-1H-咪唑-1-基)甲基]-(A) 氮丙啶乙醇衍生物 和相应的氮丙啶开环类似物可用作 X 射线治疗肿瘤的辐射增敏剂。
  • US4797397A
    申请人:——
    公开号:US4797397A
    公开(公告)日:1989-01-10
  • A new class of analog of the bifunctional radiosensitizer .alpha.-(1-aziridinylmethyl)-2-nitro-1H-imidazole-1-ethanol (RSU 1069): the cycloalkylaziridines
    作者:Mark J. Suto、Michael A. Stier、Leslie M. Werbel、Carla M. Arundel-Suto、Wilbur R. Leopold、William E. Elliott、Judith S. Sebolt-Leopold
    DOI:10.1021/jm00112a026
    日期:1991.8
    A series of compounds related to alpha-(1-aziridinylmethyl)-2-nitro-1H-imidazole-1-ethanol (RSU 1069, 1) were synthesized and evaluated as selective hypoxic cell cytotoxic agents and as radiosensitizers. The aziridine moiety was replaced with a number of other potential alkylating groups including cycloalkylaziridines and azetidines. The data indicated that modification of the aziridine of 1 resulted in a substantial decrease in the ability of the compounds to selectively kill hypoxic cells. However, these modifications did not affect the compounds' in vitro radiosensitizing activity since many of the derivatives were as potent as 1. All of the compounds that were evaluated in vivo were less toxic than 1, and several members of this series had significant activity. The best compound was trans-alpha-[[(4-bromotetrahydro-2H-pyran-3-yl)amino]methyl]-2-nitro-1H-imidazole-1-ethanol (18), which, due to its activity and log P value, is a candidate for additional in vivo studies.
查看更多